Researchers outline need for evaluation of gene expression profiling in melanoma. – Brinkwire

A consensus statement published today in JAMA Dermatology by an international group of melanoma researchers evaluates the use of prognostic genetic expression profile (GEP) testing to guide clinical management of patients with melanoma. The group cautioned against routine use of currently available GEP tests for patients with cutaneous melanoma.
Prognostic gene expression profiling is a technique that measures the expression of a particular group of genes that may help predict patient outcomes….

Click here to view the original article.